FDA Unveils 21 Policy Changes To Increase Transparency With Public
This article was originally published in The Gray Sheet
Executive Summary
FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency
You may also be interested in...
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.